Institutional members access full text with Ovid®

Share this article on:

Novel GFAP Variant in Adult-onset Alexander Disease With Progressive Ataxia and Palatal Tremor

Gass, Jennifer M. PhD*; Cheema, Anvir BSc (Hons); Jackson, Jessica MS*,†; Blackburn, Patrick R. PhD*; Van Gerpen, Jay MD; Atwal, Paldeep S. MB, ChB*,†

doi: 10.1097/NRL.0000000000000153
Case Report/Case Series

Introduction: Alexander disease is a rare neurodegenerative disease caused by variants in the glial fibrillary acidic protein gene (GFAP). This disorder can develop as an infantile, juvenile or adult-onset form and is characterized by several clinical features, including macrocephaly, seizures, ataxia, and bulbar/pseudobulbar signs. While the majority of these patients have the more progressive infantile form which causes severe leukodystrophy and early death; the less common adult form is more variable (ie, onset age, symptoms), with bulbar dysfunction as the primary feature.

Case Report: In our investigation, we describe a patient with progressive neuromuscular issues including dyspnea, dysphagia, dysarthria and progressive ataxia with palatal tremor.

Conclusions: Through genetic testing, we determined that our patient has a novel variant in GFAP typical of Alexander disease.

*Center for Individualized Medicine

Departments of Clinical Genomics

Neurology, Mayo Clinic, Jacksonville, FL

The authors declare no conflict of interest.

Reprints: Jennifer M. Gass, PhD, Center for Individualized Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224. E-mail: gass.jennifer@mayo.edu.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.